Urban T - Search Results

1

Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer.

Zalcman G, Trédaniel J, Schlichtholz B, Urban T, Milleron B, Lubin R, Meignin V, Couderc LJ, Hirsch A, Soussi T. Zalcman G, et al. Among authors: urban t. Int J Cancer. 2000 Jan 20;89(1):81-6. doi: 10.1002/(sici)1097-0215(20000120)89:1<81::aid-ijc13>3.0.co;2-i. Int J Cancer. 2000. PMID: 10719735

2

Superior vena cava syndrome in small-cell lung cancer.

Urban T, Lebeau B, Chastang C, Leclerc P, Botto MJ, Sauvaget J. Urban T, et al. Arch Intern Med. 1993 Feb 8;153(3):384-7. Arch Intern Med. 1993. PMID: 8381263

3

Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.

Urban T, Bedin A, Baud M, Chouaid C, Febvre M, Lebeau B. Urban T, et al. Lung Cancer. 1996 Feb;14(1):109-17. doi: 10.1016/0169-5002(95)00516-1. Lung Cancer. 1996. PMID: 8696714 Clinical Trial.

4

Colony-stimulating factors as an adjunct to chemotherapy in small cell lung cancer.

Urban T, Schuller MP, Lebeau B. Urban T, et al. Eur Respir J. 1996 Mar;9(3):596-602. doi: 10.1183/09031936.96.09030596. Eur Respir J. 1996. PMID: 8730024 Free article. Review.

5

Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.

Urban T, Ricci S, Lacave R, Antoine M, Kambouchner M, Capron F, Bernaudin JF. Urban T, et al. Br J Cancer. 1996 Oct;74(7):1051-5. doi: 10.1038/bjc.1996.488. Br J Cancer. 1996. PMID: 8855973 Free PMC article.

6

MDR1-Pgp 170 expression in human bronchus.

Lechapt-Zalcman E, Hurbain I, Lacave R, Commo F, Urban T, Antoine M, Milleron B, Bernaudin JF. Lechapt-Zalcman E, et al. Among authors: urban t. Eur Respir J. 1997 Aug;10(8):1837-43. doi: 10.1183/09031936.97.10081837. Eur Respir J. 1997. PMID: 9272928 Free article.

7

Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.

Zalcman G, Schlichtholz B, Trédaniel J, Urban T, Lubin R, Dubois I, Milleron B, Hirsch A, Soussi T. Zalcman G, et al. Among authors: urban t. Clin Cancer Res. 1998 Jun;4(6):1359-66. Clin Cancer Res. 1998. PMID: 9626451

8

Prognostic significance of supraclavicular lymph nodes in small cell lung cancer: a study from four consecutive clinical trials, including 1,370 patients. "Petites Cellules" Group.

Urban T, Chastang C, Vaylet F, Mathieu M, Leclerc P, Paillotin D, Lebeau B. Urban T, et al. Chest. 1998 Dec;114(6):1538-41. doi: 10.1378/chest.114.6.1538. Chest. 1998. PMID: 9872184

9

Standard combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. 'Petites Cellules' Group.

Urban T, Baleyte T, Chastang CL, Jeannin L, Delaval P, Zaegel M, Mornet M, Coetmeur D, Lebeau B. Urban T, et al. Lung Cancer. 1999 Aug;25(2):105-13. doi: 10.1016/s0169-5002(99)00050-1. Lung Cancer. 1999. PMID: 10470844 Clinical Trial.

10

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.

Lebeau B, Urban T, Bréchot JM, Paillotin D, Vincent J, Leclerc P, Meekel P, L'Her P, Lebas FX, Chastang C. Lebeau B, et al. Among authors: urban t. Cancer. 1999 Oct 15;86(8):1480-7. Cancer. 1999. PMID: 10526276 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters